Targeting inflammatory pathways for treatment of major depressive disorder

CR Patil, CS Gawli, S Bhatt - Drug Discovery Today, 2023 - Elsevier
Current treatments modalities for major depressive disorder (MDD) mainly target
monoaminergic neurotransmission. However, the therapeutic inadequacy and adverse …

Immunotherapy for depression: Recent insights and future targets

Y Bai, Y Cai, D Chang, D Li, X Huo, T Zhu - Pharmacology & Therapeutics, 2024 - Elsevier
Depression stands as a prominent contributor to global disability, entailing an elevated risk
of suicide. Substantial evidence supports the notion that immune dysregulation may play a …

Morinda officinalis oligosaccharides mitigate depression-like behaviors in hypertension rats by regulating Mfn2-mediated mitophagy

L Yang, Y Ao, Y Li, B Dai, J Li, W Duan, W Gao… - Journal of …, 2023 - Springer
Objective Patients with hypertension have a risk of depression. Morinda officinalis
oligosaccharides (MOOs) have anti-depressant properties. In this study, we aimed to …

NLRP3 inflammasome regulates astrocyte transformation in brain injury induced by chronic intermittent hypoxia

N She, Y Shi, Y Feng, L Ma, Y Yuan, Y Zhang, Z Cao… - BMC neuroscience, 2022 - Springer
Background Obstructive sleep apnea (OSA) is mainly characterized by sleep fragmentation
and chronic intermittent hypoxia (CIH), the latter one being associated with multiple organ …

Depression as a risk factor for dementia: a meta-analysis

R Fernández Fernández, JI Martín… - The Journal of …, 2024 - Am Neuropsych Assoc
Dementia is a syndrome characterized by the deterioration of cognitive function beyond
what is expected. The increased risk of developing this syndrome resulting from established …

CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk

Y Liao, Y Wang, QQ Tao, C Yang, J Wang… - Alzheimer's & …, 2023 - Wiley Online Library
INTRODUCTION Depression is considered a prodromal state of Alzheimer's disease (AD),
yet the underlying mechanism (s) by which depression increases the risk of AD are not …

Corticotropin‐releasing factor signaling and its potential role in the prefrontal cortex‐dependent regulation of anxiety

X Yang, F Geng - Journal of Neuroscience Research, 2023 - Wiley Online Library
A large body of literature has highlighted the significance of the corticotropin‐releasing
factor (CRF) system in the regulation of neuropsychiatric diseases. Anxiety disorders are …

The neuropharmacological evaluation of seaweed: A potential therapeutic source

K Jannat, R Balakrishnan, JH Han, YJ Yu, GW Kim… - Cells, 2023 - mdpi.com
The most common neurodegenerative diseases (NDDs), such as Alzheimer's disease (AD)
and Parkinson's disease (PD), are the seventh leading cause of mortality and morbidity in …

[HTML][HTML] m 6A methylation in cellular senescence of age-associated diseases: m 6A methylation in cellular senescence of age-associated diseases

P Gao, F Yao, J Pang, K Yin, X Zhu - Acta Biochimica et Biophysica …, 2023 - ncbi.nlm.nih.gov
Cellular senescence is a state of irreversible cellular growth arrest that occurs in response to
various stresses. In addition to exiting the cell cycle, senescent cells undergo many …

[HTML][HTML] Copper neurotoxicity: Induction of cognitive dysfunction: A review

D Feng, Y Zhao, W Li, X Li, J Wan, F Wang - Medicine, 2023 - journals.lww.com
Cognitive dysfunction occurs mainly in certain diseases and in the pathological process of
aging. In addition to this, it is also widespread in patients undergoing anesthesia, surgery …